Clinical trial
Evaluation of Neointimal Coverage of Everolimus-Eluting Stent and Bare-metal Stent After Implantation in STEMI Patients by Optical Coherence Tomography
NCT01875835 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Neointimal Coverage of Everolimus-Eluting Stent and Bare-metal Stent After Implantation in STEMI Patients by Optical Coherence Tomography
- Lead sponsor
- Harbin Medical University
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- June 30, 2013
- Completion date
- February 29, 2016
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute myocardial infarction